Stem cell-based tissue engineering is poised to revolutionize the treatment of musculoskeletal injuries. However, in order to overcome scientific, practical, and regulatory obstacles and optimize therapeutic strategies, it is essential to better understand the mechanisms underlying the pro-regenerative effects of stem cells. There has been an attempted paradigm shift within the last decade to think of transplanted stem cells as "medicinal" therapies that orchestrate healing on the basis of their secretome and immunomodulatory profiles rather than acting as bona fide stem cells that proliferate, differentiate, and directly produce matrix to form tissues. Yet the majority of current bone and skeletal muscle tissue de novo engineering strategies are still premised on a direct contribution of stem cells as building blocks to tissue regeneration. Our review of the recent literature finds that researchers continue to focus on the quantification of de bone/skeletal muscle tissue following treatment and few studies aim novo to address this mechanistic conundrum directly. The dichotomy of thought is reflected in the diversity of new advances ranging from in situ three-dimensional bioprinting to a focus on exosomes and extracellular vesicles. However, recent findings elucidating the role of the immune system in tissue regeneration combined with novel imaging platform technologies will have a profound impact on our future understanding of how stem cells promote healing following biomaterial-mediated delivery to defect sites.
Introduction
Bone and skeletal muscle both have high self-healing capacities that become overwhelmed when loss of large tissue volumes results in critical-sized bone defects or volumetric muscle loss (VML). Current pre-clinical tissue engineering strategies for musculoskeletal defects employ bone marrow-derived mesenchymal stem cells (MSCs), adipose-derived stromal/stem cells (ASCs), other tissue-derived stem cell populations, and induced pluripotent stem cells (iPSCs). However, although there are over 200 clinical trials involving ASCs and MSCs in the US (www.clinicaltrials.gov), very few of these trials involve tissue engineering strategies to regenerate musculoskeletal tissues. There are considerable scientific, practical, and regulatory hurdles that so far have restricted the translational use of stem cells for these applications. Underlying all of these hurdles is a dearth of understanding of the mechanism by which transplanted cells promote regeneration. This has imposed significant limitations on our ability to optimize key parameters such as stem cell purity, dosing, priming, delivery, or the design of scaffold biomaterials. In fact, the majority of clinical trials are not using ASCs/MSC for direct differentiation and contribution to tissue repair but rely on paracrine mechanisms. Yet few recent studies have focused on improving our understanding of the fate of transplanted cells. In spite of this, a convergence of stem cell-based tissue engineering with recent advances in imaging technologies and immunoengineering may open a window of opportunity for further exploration and the discovery of new insights.
Transplanted stem cells orchestrate musculoskeletal tissue repair
Bone tissue engineering The current gold standard of treatment of the critical-sized bone defect is the cancellous autograft, often harvested from the iliac crest 1 . Autografts repair bone via osseointegration and osteoconduction, but the use of these grafts is limited by donor site morbidity, risk of infection, risk of surgical complications, and limited available bone volume 2 ; thus, tissue engineering provides a promising alternative. Most musculoskeletal tissue engineering studies operate on the premise that stem cells seeded into biomaterial scaffolds and implanted into volumetric defects survive the ensuing ischemic microenvironment, differentiate into osteoblasts or myocytes, and integrate with the native matrix to directly impact tissue regeneration 3 . Hence, technologies such as in situ bioprinting are continually being advanced to precisely control the spatial location of cells and assess the impact of different "geometries" . Other recent studies to achieve bone healing examined the effect of stimulating endochondral ossification with ASCs differentiated into hypertrophic chondrocytes and implanted into a rat femoral defect. They hypothesize that implanted hypertrophic chondrocytes help to both regulate endogenous cell behavior and directly contribute to bone formation; however, they did not determine whether improved bone formation was predominantly due to the survival and integration of the implanted cells or to their superior secretory and immunomodulatory properties 5 21, 23 , and further work is necessary to characterize the therapeutic mechanism of transplanted iPSC-derived cells. An emergent alternative to the treatment of VML is the use of autologous minced muscle grafts, or 1 mm 3 pieces of muscle, which have also been demonstrated to attenuate T lymphocyte and macrophage responses to severe muscle injury. These results may indicate a promising therapeutic role for cell aggregates and immunomodulatory therapies in the treatment of VML 25 .
Modulating the survival and secretory profile of transplanted stem cells
Tissue engineering studies continue to prioritize the "direct contribution" paradigm. They focus largely on the quantification of de novo bone/skeletal muscle tissue and the positive effects of stem cell delivery. However, most studies do not track implanted cells in vivo or quantify their viability over a long time course. Multiple studies that have tracked transplanted cells have demonstrated that few cells survive more than 4 to 8 weeks following transplantation, suggesting that their pro-regenerative outcomes might be more correctly attributed to indirect mechanisms such as cytokine secretion, immunomodulation, and signaling to endogenous cells 26, 27 . For example, a recent study in which ASCs were injected systemically or locally into a wound bed showed that systemically delivered ASCs became trapped in the lung and could not be detected 72 hours after systemic injection but that locally injected cells remained strongly detectable up to 7 days at the wound site, yet both groups exhibited enhanced wound healing 28 . Recently, some groups have investigated stem cell aggregation and its impact on metabolic and secretory profiles while other studies of exosomes and extracellular vesicles (EVs) have been performed in an effort to provide greater insights into the potency of transplanted stem cells.
Stem cell aggregates
Implanting stem cells as aggregates rather than monodispersed cells has been shown to enhance their viability, migration, and differentiation and modifies their secretion of cytokines, immunomodulatory factors, and EVs to improve therapeutic outcomes 29, 30 . Yet the lack of standardization renders it impossible to accurately correlate the impact of aggregate sizes, methods of aggregation, and mode of implantation on the therapeutic outcomes. 49, 50 , photoacoustic imaging 51 , ultrasound, and magnetic particle imaging 52 may also be applied to the in vivo visualization of implanted stem cells.
Concluding statements
Future advances toward the clinical application of stem cells for musculoskeletal treatments will require that tissue engineering studies move beyond empirical readouts and employ more rigorous tools to identify the molecular mechanisms underlying regenerative outcomes. Specifically, there needs to be a greater emphasis on the development and use of novel imaging techniques (to spatially map transplanted and endogenous stem cells and immune cells in tissue-engineered grafts post-implantation to visualize cell fates and interactions) as well as on coupling these data with single-cell analytics. The combined application of these advanced molecular tools will enable further insight into the actual role that stem cells are playing and will facilitate better targeting and optimization of their use in promoting tissue regeneration.
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